Overview
- Live coverage was halted and reporters were escorted out after a man standing behind President Trump fainted during the announcement, then the briefing resumed with officials saying he was okay.
- Novo Nordisk disputed widespread reports that the individual was executive Gordon Findlay, stating he was not present and that only Mike Doustdar and Dave Moore represented the company.
- Dr. Mehmet Oz, the CMS administrator, and others assisted as Eli Lilly CEO David Ricks was speaking, with video capturing someone asking, “Gordon, you OK?” before feeds were cut.
- The White House has not released the man’s identity and no cause for the collapse has been confirmed.
- Trump announced agreements with Eli Lilly and Novo Nordisk to offer GLP‑1 drugs such as Wegovy and Zepbound at steep discounts with expanded Medicare and Medicaid coverage, including a planned direct‑to‑consumer TrumpRx.gov option next year.